1. ACALABRUTINIB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: FINAL RESULTS FROM A PHASE 2 STUDY. (17th June 2021) Authors: Wang, M.; Rule, S.; Zinzani, P. L.; Goy, A.; Casasnovas, O.; Smith, S. D.; Damaj, G.; Doorduijn, J. K.; Lamy, T.; Morschhauser, F.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Dupuis, J.; Jacobsen, E.; Kater, A. P.; Le Gouill, S.; Oberic, L.; Robak, T. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA. (12th June 2019) Authors: Kim, W.S.; Assouline, S.; Bartlett, N.L.; Bosch, F.; Budde, L.E.; Cheah, C.; Gregory, G.P.; Hong, J.; Ku, M.; Marlton, P.; Matasar, M.; Nastoupil, L.; Panizo, C.; Sehn, L.H.; Tzachanis, D.; Chu, W.; Hernandez, M.G.; Kwan, A.; Li, C.C.; Sison, I. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antidesmocollin 1 autoantibody negative subcorneal pustular dermatosis‐type IgA pemphigus associated with multiple myeloma. (1st January 2015) Authors: España, A.; Gimenez‐Azcarate, A.; Ishii, N.; Idoate, M.A.; Panizo, C.; Hashimoto, T. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antidesmocollin 1 autoantibody negative subcorneal pustular dermatosis‐type IgA pemphigus associated with multiple myeloma. (8th December 2014) Authors: España, A.; Gimenez‐Azcarate, A.; Ishii, N.; Idoate, M.A.; Panizo, C.; Hashimoto, T. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AUTOLOGOUS STEM CELL TRANSPLANTATION AS PART OF FIRST‐LINE THERAPY IN PATIENTS WITH PERIPHERAL T‐CELL LYMPHOMA: A MULTICENTER GELTAMO/FIL STUDY. (12th June 2019) Authors: Lopez‐Parra, M.; Bellei, M.; Rambaldi, A.; Novelli, S.; Panizo, C.; Martelli, M.; Dhouly, I.; Bastos, M.; Gutierrez, A.; Sancho, J.; Ramirez, M.; Moraleda, J.; Carrillo Cruz, E.; Jimenez Ubieto, A.; Jarque, I.; Vittolo, U.; de las Heras, N.; Arranz, R.; Lopez‐Jimenez, J.; Montalbán, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EFFECTS ON THE HUMAN IMMUNE SYSTEM AFTER OBINUTUZUMAB MONOTHERAPY TREATMENT. (June 2017) Authors: Garcia‐Munoz, R.; Aguinaga, L.; Feliu, J.; Anton‐Remirez, J.; Jorge del Val, L.; Dominguez‐Garrido, E.; Rabasa, P.; Panizo, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LONG‐TERM RESULTS OF THE MULTICENTER PHASE II TRIAL WITH BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT FOR PATIENTS WITH MALT LYMPHOMA (MALT‐2008‐01). (June 2017) Authors: Salar, A.; Domingo‐Domenech, E.; Panizo, C.; Nicolás, C.; Bargay, J.; Muntañola, A.; Canales, M.; Bello, J.; Sancho, J.; Tomás, J.; Rodriguez, M.; Peñalver, F.J.; Palomera, L.; Grande, C.; Sánchez‐Blanco, J.J.; Arranz, R.; Conde, E.; Garcia, M.; García, J.F.; Caballero, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1131: POST HOC ANALYSIS OF PATIENTS WITH HIGHLY PROLIFERATIVE VARIANTS OF MANTLE CELL LYMPHOMA TREATED WITH ACALABRUTINIB. (23rd June 2022) Authors: Le Gouill, S.; Długosz-Danecka, M.; Rule, S.; Luigi Zinzani, P.; Goy, A.; Smith, S. D.; Doorduijn, J. K.; Panizo, C.; Shah, B.; Davies, A.; Eek, R.; Jacobsen, E.; Kater, A. P.; Robak, T.; Jain, P.; Calvo, R.; Yang, H.; Wang, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Tamariz-Amador, L.-E.; Battaglia, A. M.; Maia, C.; Zherniakova, A.; Guerrero, C.; Zabaleta, A.; Burgos, L.; Botta, C.; Fortuño, M.-A.; Alignani, D.; Blanco, L.; Grande, C.; Manubens, A.; Arguiñano, J.-M.; Gomez, C.; Perez-Persona, E.; Olazabal, I.; Oiartzabal, I.; Panizo, C.; Prosper, F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. POLATUZUMAB VEDOTIN (POLA) + OBINUTUZUMAB (G) + LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE IB/II INTERIM ANALYSIS. (12th June 2019) Authors: Diefenbach, C.; Kahl, B.; Banerjee, L.; McMillan, A.; Ramchandren, R.; Miall, F.; Briones, J.; Cordoba, R.; Gonzalez‐Barca, E.; Panizo, C.; Hirata, J.; Chang, N.; Musick, L.; Abrisqueta, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗